You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
22 February 2011Endoscopic detection of murine colonic dysplasia using a novel fluorescence-labeled peptide
Current endoscopic screening does not detect all pre-malignant (dysplastic) colorectal mucosa, thus requiring the
development of more sensitive, targeted techniques to improve detection. The presented work utilizes phage display
to identify a novel peptide binder to colorectal dysplasia in a CPC;Apc mouse model. A wide-field, small animal
endoscope capable of fluorescence excitation (450-475 nm) identified polyps via white light and also collected
fluorescence images (510 nm barrier filter) of peptide binding. The peptide bound ~2-fold greater to the colonic
adenomas when compared to the control peptide. We have imaged fluorescence-labeled peptide binding in vivo that
is specific towards distal colonic adenomas.
The alert did not successfully save. Please try again later.
Sharon J. Miller, Bishnu P. Joshi, Adam Gaustad, Eric R. Fearon, Thomas D. Wang, "Endoscopic detection of murine colonic dysplasia using a novel fluorescence-labeled peptide," Proc. SPIE 7893, Endoscopic Microscopy VI, 789303 (22 February 2011); https://doi.org/10.1117/12.873530